Memantin Aristo

Memantine, the active ingredient in Memantin Aristo, is a NMDA receptor antagonist presented as an oral formulation for oral use. It works by modulating glutamatergic activity through a non‑competitive mechanism at the NMDA receptor and is indicated for the treatment of moderate to severe Alzheimer’s disease in adult patients, helping to preserve cognition and daily functioning, and providing a therapeutic option when cholinesterase inhibitors are insufficient.

GNH USA supplies Memantin Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Memantin Aristo is used in the management of Alzheimer’s disease, targeting glutamatergic neurotransmission.

Alzheimer’s disease (moderate to severe): Improves cognitive function, daily living activities and overall clinical status in patients with moderate to severe disease. Behavioral symptoms of Alzheimer’s disease: May reduce agitation, aggression and psychotic features associated with the condition. Dementia due to Alzheimer’s disease: Supports maintenance of functional abilities and slows progression of cognitive decline.

Memantin Aristo may be associated with a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Dizziness - Headache - Constipation - Confusion - Fatigue - Hypertension

Serious or Rare Side Effects: - Seizures - Severe allergic reactions (e.g., anaphylaxis, Stevens‑Johnson syndrome) - Hepatic dysfunction - Cardiac arrhythmias - Psychosis or severe agitation

When prescribing Memantin Aristo, clinicians should consider several safety factors. - Renal impairment: dose adjustment may be required and renal function should be monitored. - History of seizures: monitor closely for increased seizure activity. - Cardiovascular disease: use with caution in patients with uncontrolled hypertension or arrhythmias. - Concurrent use with other NMDA antagonists: avoid additive neurotoxicity. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at room temperature: keep in the original pack, protect from moisture.

Memantin Aristo can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Amantadine: additive NMDA antagonism may increase toxicity. - Ketamine: combined NMDA blockade can lead to severe neuropsychiatric effects. - High‑dose anticholinergics: may blunt therapeutic benefit.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may reduce cognitive improvement. - CNS depressants (e.g., benzodiazepines): may enhance dizziness and sedation. - Diuretics: may affect renal clearance of memantine, requiring dose review.